Spit test aims to predict prostate cancer risk across ethnicities
NCT ID NCT06636526
Summary
This study is testing a new saliva-based DNA test designed to estimate a person's future risk of developing prostate cancer. It aims to recruit 1000 men aged 40-55 from three different ethnic backgrounds to see how well the test works for everyone. Participants identified as higher risk will be offered annual prostate cancer screening for three years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust
RECRUITINGSutton, Surrey, SM2 5PT, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The Royal Marsden Hospital
RECRUITINGLondon, SW3 6JJ, United Kingdom
Contact Email: •••••@•••••
-
The Royal Marsden Hospital
RECRUITINGSutton, SM2 5PT, United Kingdom
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.